Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Heart Failure Therapeutics Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Heart Failure Therapeutics Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Diagnosis
      • 1.3.3 Prognosis
      • 1.3.4 Treatment Options and Treatment Algorithm
    • 1.4 Market Segment by Application
      • 1.4.1 Global Heart Failure Therapeutics Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Clinic
      • 1.4.4 Medical Research Organization
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Heart Failure Therapeutics Market Size
      • 2.1.1 Global Heart Failure Therapeutics Revenue 2014-2025
      • 2.1.2 Global Heart Failure Therapeutics Sales 2014-2025
    • 2.2 Heart Failure Therapeutics Growth Rate by Regions
      • 2.2.1 Global Heart Failure Therapeutics Sales by Regions 2014-2019
      • 2.2.2 Global Heart Failure Therapeutics Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Heart Failure Therapeutics Sales by Manufacturers
      • 3.1.1 Heart Failure Therapeutics Sales by Manufacturers 2014-2019
      • 3.1.2 Heart Failure Therapeutics Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Heart Failure Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.2.2 Heart Failure Therapeutics Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Heart Failure Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.3 Heart Failure Therapeutics Price by Manufacturers
    • 3.4 Key Manufacturers Heart Failure Therapeutics Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Heart Failure Therapeutics Market
    • 3.6 Key Manufacturers Heart Failure Therapeutics Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Diagnosis Sales and Revenue (2014-2019)
      • 4.1.2 Prognosis Sales and Revenue (2014-2019)
      • 4.1.3 Treatment Options and Treatment Algorithm Sales and Revenue (2014-2019)
    • 4.2 Global Heart Failure Therapeutics Sales Market Share by Type
    • 4.3 Global Heart Failure Therapeutics Revenue Market Share by Type
    • 4.4 Heart Failure Therapeutics Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Heart Failure Therapeutics Sales by Application

    6 United States

    • 6.1 United States Heart Failure Therapeutics Breakdown Data by Company
    • 6.2 United States Heart Failure Therapeutics Breakdown Data by Type
    • 6.3 United States Heart Failure Therapeutics Breakdown Data by Application

    7 European Union

    • 7.1 European Union Heart Failure Therapeutics Breakdown Data by Company
    • 7.2 European Union Heart Failure Therapeutics Breakdown Data by Type
    • 7.3 European Union Heart Failure Therapeutics Breakdown Data by Application

    8 China

    • 8.1 China Heart Failure Therapeutics Breakdown Data by Company
    • 8.2 China Heart Failure Therapeutics Breakdown Data by Type
    • 8.3 China Heart Failure Therapeutics Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Heart Failure Therapeutics Breakdown Data by Company
    • 9.2 Rest of World Heart Failure Therapeutics Breakdown Data by Type
    • 9.3 Rest of World Heart Failure Therapeutics Breakdown Data by Application
    • 9.4 Rest of World Heart Failure Therapeutics Breakdown Data by Countries
      • 9.4.1 Rest of World Heart Failure Therapeutics Sales by Countries
      • 9.4.2 Rest of World Heart Failure Therapeutics Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Bayer
      • 10.1.1 Bayer Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Heart Failure Therapeutics
      • 10.1.4 Heart Failure Therapeutics Product Introduction
      • 10.1.5 Bayer Recent Development
    • 10.2 Cynokinetics
      • 10.2.1 Cynokinetics Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Heart Failure Therapeutics
      • 10.2.4 Heart Failure Therapeutics Product Introduction
      • 10.2.5 Cynokinetics Recent Development
    • 10.3 Les Laboratoires Servier
      • 10.3.1 Les Laboratoires Servier Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Heart Failure Therapeutics
      • 10.3.4 Heart Failure Therapeutics Product Introduction
      • 10.3.5 Les Laboratoires Servier Recent Development
    • 10.4 Merck & Co.
      • 10.4.1 Merck & Co. Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Heart Failure Therapeutics
      • 10.4.4 Heart Failure Therapeutics Product Introduction
      • 10.4.5 Merck & Co. Recent Development
    • 10.5 Novartis
      • 10.5.1 Novartis Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Heart Failure Therapeutics
      • 10.5.4 Heart Failure Therapeutics Product Introduction
      • 10.5.5 Novartis Recent Development
    • 10.6 Procoralan
      • 10.6.1 Procoralan Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Heart Failure Therapeutics
      • 10.6.4 Heart Failure Therapeutics Product Introduction
      • 10.6.5 Procoralan Recent Development
    • 10.7 Bristol-Myers Squibb Company
      • 10.7.1 Bristol-Myers Squibb Company Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Heart Failure Therapeutics
      • 10.7.4 Heart Failure Therapeutics Product Introduction
      • 10.7.5 Bristol-Myers Squibb Company Recent Development
    • 10.8 Cardiorentis AG
      • 10.8.1 Cardiorentis AG Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Heart Failure Therapeutics
      • 10.8.4 Heart Failure Therapeutics Product Introduction
      • 10.8.5 Cardiorentis AG Recent Development
    • 10.9 CVie Therapeutics Limited
      • 10.9.1 CVie Therapeutics Limited Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Heart Failure Therapeutics
      • 10.9.4 Heart Failure Therapeutics Product Introduction
      • 10.9.5 CVie Therapeutics Limited Recent Development
    • 10.10 Orion Corporation
      • 10.10.1 Orion Corporation Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Heart Failure Therapeutics
      • 10.10.4 Heart Failure Therapeutics Product Introduction
      • 10.10.5 Orion Corporation Recent Development
    • 10.11 PhaseBio Pharmaceuticals
    • 10.12 Market Segment by Product Type
    • 10.13 B-Blockers
    • 10.14 Calcium Channel Blockers
    • 10.15 Cardiac Glycosides
    • 10.16 Diuretics
    • 10.17 Morphine
    • 10.18 Vasodilators/Nitrates

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Heart Failure Therapeutics Sales Channels
      • 11.2.2 Heart Failure Therapeutics Distributors
    • 11.3 Heart Failure Therapeutics Customers

    12 Market Forecast

    • 12.1 Global Heart Failure Therapeutics Sales and Revenue Forecast 2019-2025
    • 12.2 Global Heart Failure Therapeutics Sales Forecast by Type
    • 12.3 Global Heart Failure Therapeutics Sales Forecast by Application
    • 12.4 Heart Failure Therapeutics Forecast by Regions
      • 12.4.1 Global Heart Failure Therapeutics Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Heart Failure Therapeutics Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Heart failure (HF), often referred to as congestive heart failure (CHF), is when the heart is unable to pump sufficiently to maintain blood flow to meet the body's needs. Signs and symptoms commonly include shortness of breath, excessive tiredness, and leg swelling.The shortness of breath is usually worse with exercise, while lying down, and may wake the person at night.A limited ability to exercise is also a common feature. Chest pain, including angina, does not typically occur due to heart failure.
      In 2019, the market size of Heart Failure Therapeutics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Heart Failure Therapeutics.

      This report studies the global market size of Heart Failure Therapeutics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Heart Failure Therapeutics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Bayer
      Cynokinetics
      Les Laboratoires Servier
      Merck & Co.
      Novartis
      Procoralan
      Bristol-Myers Squibb Company
      Cardiorentis AG
      CVie Therapeutics Limited
      Orion Corporation
      PhaseBio Pharmaceuticals
      Market Segment by Product Type
      B-Blockers
      Calcium Channel Blockers
      Cardiac Glycosides
      Diuretics
      Morphine
      Vasodilators/Nitrates

      Market Segment by Product Type
      Diagnosis
      Prognosis
      Treatment Options and Treatment Algorithm

      Market Segment by Application
      Hospital
      Clinic
      Medical Research Organization

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Heart Failure Therapeutics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Heart Failure Therapeutics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Heart Failure Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now